Unique ID issued by UMIN | UMIN000051748 |
---|---|
Receipt number | R000059061 |
Scientific Title | A study to evaluate the dose-response efficacy of body fat reduction by continuous ingestion of test food. (SWE-2023-07-HCRINK) |
Date of disclosure of the study information | 2023/07/30 |
Last modified on | 2024/05/08 09:07:24 |
A study to evaluate the dose-response efficacy of body fat reduction by continuous ingestion of test food. (SWE-2023-07-HCRINK)
A study to evaluate the dose-response efficacy of body fat reduction by continuous ingestion of test food.
A study to evaluate the dose-response efficacy of body fat reduction by continuous ingestion of test food. (SWE-2023-07-HCRINK)
A study to evaluate the dose-response efficacy of body fat reduction by continuous ingestion of test food.
Japan |
Not applicable
Not applicable | Adult |
Others
NO
To evaluate the dose-response efficacy of body fat reduction by continuous ingestion of test food.
Efficacy
Abdominal total fat area
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
4
Prevention
Food |
Intake of the high-dose test foods for 12 weeks.
Intake of the medium-dose test foods for 12 weeks.
Intake of the low-dose test foods for 12 weeks.
Intake of the control foods for 12 weeks.
20 | years-old | <= |
65 | years-old | > |
Male and Female
(1) Males and females who are 20 -< years old < 65 from the time of IC acquisition to the end of the study.
(2) Subjects who can come to the designated premises on the date of the scheduled visit.
(3) Subjects who can understand the purpose and content of this study and agree in writing to participate in this study.
(1) Subjects who have regular hard exercise.
(2) Heavy drinker of alcohol and heavy smoker
(3) Subjects who use of products affecting the data of this study, such as food for specified health use, and food with function claims.
(4) Subjects who continuously take medicines.
(5) Subjects who are participating in other study or planning to participate or participated within the past 4 weeks.
(6) Subjects who are:
a) heart, liver, or kidney disease (including complications of other diseases)
b) undergoing treatment for or have a history of cardiovascular disease
c) diabetes
d) allergic to test foods
e) undergoing treatment for or have a history of serious diseases such as cancer or tuberculosis
f) having history of comorbidities in the gastrointestinal tract (excluding a history of cecum)
(7) Others who are judged inappropriate for participant by the investigator
200
1st name | Hidenori |
Middle name | |
Last name | Obata |
Suntory Wellness Limited
Institute for Science of Life
619-0284
8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto. 619-0284, Japan
050-3182-0568
Hidenori_Obata@suntory.co.jp
1st name | Mui |
Middle name | |
Last name | Iida |
Suntory Wellness Limited
Institute for Science of Life
619-0284
8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto. 619-0284, Japan
050-1734-9361
Mui_Iida@suntory.co.jp
Suntory Wellness Limited
Suntory Wellness Limited
Profit organization
Medical Corporation Jikokai Fukuzumi Internal Medicine Clinic IRB
5th floor of the Ito-Yokado Fukuzumi store, 2-1-2-5 Fukuzumi, Toyohira-ku, Sapporo-shi, Hokkaido
011-836-3531
shibata@jkkai.or.jp
NO
2023 | Year | 07 | Month | 30 | Day |
Unpublished
Completed
2023 | Year | 07 | Month | 29 | Day |
2023 | Year | 07 | Month | 28 | Day |
2023 | Year | 07 | Month | 31 | Day |
2023 | Year | 12 | Month | 16 | Day |
2023 | Year | 07 | Month | 29 | Day |
2024 | Year | 05 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059061